Home
Explore
Substances
Ailments
Problem Substances
Therapeutic Actions
Problematic Actions
Pharmacological Actions
Adverse Pharmacological Actions
Keywords
Health Guides
Recent Comments
Authors
GMTV
Tools
SS - Query Diseases
SS - Query Pharmacological Actions
SS - Query Substances
Articles
Most Popular
Most Recent
Eatmology
Store
Membership Options
Books
Downloadable Documents
Events
Event Videos
GMI Tokens
Donate
My Account
My Comments
My Cart
My Newsletters
FAQ
Contact
Search this site:
Search
Download Now
Your Token Count
0
Sign in to Purchase/Download Documents
Sign in
/
Register
User login
Username or e-mail:
*
Password:
*
Log in
Create new account
Request new password
Social Networking
Support Free Media
Become A Sponsor
View Our Sponsors
Advertise/Collaborate
Become a Member
Become an Affiliate
Link To Us
About Us
Hemolytic
0
Tweet
User Options
Hover over an icon for more information
Additional Topics Details for this Page
Article Count
- 4
Cumulative Knowledge
- 18
Advanced Database Options
Limit Articles Displayed by the Following Study Types
Human Study
Human: Case Report
In Vitro Study
Submit
Available Sorting Options
Limited to Members Only
By default, all articles on GreenMedInfo.com are sorted based on the content type which best reflects the data which most users are searching for. For instance, people viewing substances are generally most interested in viewing diseases that these substances have shown to have positive influences. This section is for allowing more advanced sorting methods. Currently, these advanced sorting methods are available for members only. If you are already a member, you can sign in by
clicking here
. If you do not currently have a user account, and would like to create one/become a member,
click here
to begin the singup process.
Currently Available Sorting Options
Article Published Date
- Sort all displayed articles by their published date
Quick Summary Fieldsets
- Sort alphabetically, rather than by Cumulative Knowledge
Cumulative Knowledge
- Default sorting method. Allows you to sort descendingly
What is Cumulative Knowledge?
Cumulative Knowledge
is determined by ascribing a numerical value to the various study types weighted in descending order as follows: (1) Meta-Analysis; (2) Human Study; (3) Human: Case Study; (4) Animal: Transgenic; (5) Animal; (6) In Vitro; (7) Review; and (8) Commentary.
Click here for a more thorough explanation.
Quick Summary: Current access displays 2 out of 5 associated Problem Substances
Name
Cumulative Knowledge
Article Count
Focus Articles
Aspirin
10
1
Log in
|
Sign up
Cefazolin
6
2
Log in
|
Sign up
Quick Summary: Current access displays 2 out of 5 associated Diseases
Name
Cumulative Knowledge
Article Count
Focus Articles
Anemia: Hemolytic
10
1
Log in
|
Sign up
Glucose-6-phosphate-dehydrogenase-deficient (G-6-PD-deficient)
10
1
Log in
|
Sign up
Currently Viewing Free Sample of Member Only Features
Although all 19,000+ articles on GreenMedInfo.com are made entirely free to view as an educational service to the public, we provide a powerful set of enhanced data comprehension and retrieval tools for subscribing members. Above you are viewing a free preview, limited to 2 rows, of the membership feature called "
Cumulative Knowledge
" (
learn more
).
The
Focus Article Feature
is not enabled.
Upgrading to the
Member
role gives you access to unlimited rows of Cumulative Knowledge data.
To Participate
Click here
to login
Click here
to create an account
View the Evidence: Adverse Pharmacological Actions
Aspirin (Acetylsalicylic acid) may cause severe hemolytic anemia in some glucose-6-phosphate-dehydrogenase-deficient (G-6-PD-deficient) individuals.
Click here to read the entire abstract
Pubmed Data
: J Clin Invest. 1970 Jul;49(7):1334-40. PMID:
5432368
Article Published Date
: Jul 01, 1970
Study Type
: Human Study
Additional Links
Diseases
:
Anemia: Hemolytic : CK(76) : AC(8)
,
Glucose-6-phosphate-dehydrogenase-deficient (G-6-PD-deficient) : CK(10) : AC(1)
,
Glucosephosphate Dehydrogenase Deficiency : CK(11) : AC(2)
Problem Substances
:
Aspirin : CK(471) : AC(64)
Adverse Pharmacological Actions
:
Hemolytic : CK(17) : AC(4)
Cefazolin-induced hemolytic anemia has been reported.
Click here to read the entire abstract
Pubmed Data
: Clin Orthop Relat Res. 2007 Jun;459:260-2. PMID:
17308481
Article Published Date
: Jun 01, 2007
Study Type
: Human: Case Report
Additional Links
Diseases
:
Hemolytic Anemia : CK(75) : AC(5)
Problem Substances
:
Cefazolin : CK(6) : AC(2)
Adverse Pharmacological Actions
:
Hemolytic : CK(17) : AC(4)
Hemolysis induced by cefazolin and cephalothin in a patient with penicillin sensitivity has been reported.
Click here to read the entire abstract
Pubmed Data
: Transfusion. 1978 May-Jun;18(3):369-73. PMID:
96555
Article Published Date
: May 01, 1978
Study Type
: Human: Case Report
Additional Links
Diseases
:
Drug-Induced Toxicity : CK(560) : AC(78)
Problem Substances
:
Cefazolin : CK(6) : AC(2)
,
Cephalothin : CK(3) : AC(1)
Adverse Pharmacological Actions
:
Hemolytic : CK(17) : AC(4)
Aluminium hydroxide and calcium phosphate adjuvants have a immunotoxic and haemolytic effects.
Click here to read the entire abstract
Pubmed Data
: Vaccine. 1993;11(9):914-8. PMID:
8212836
Article Published Date
: Jan 01, 1993
Study Type
: In Vitro Study
Additional Links
Additional Keywords
:
Adjuvant Toxicity : CK(16) : AC(5)
Problem Substances
:
Aluminum Hydroxide : CK(56) : AC(14)
,
Calcium Phosphate : CK(6) : AC(4)
Adverse Pharmacological Actions
:
Hemolytic : CK(17) : AC(4)
,
Immunosuppressive : CK(155) : AC(23)
,
Immunotoxic : CK(230) : AC(38)
Polymeric (polystyrene) nano particles have hemolytic properties.
Click here to read the entire abstract
Pubmed Data
: IEEE Trans Nanobioscience. 2011 Dec ;10(4):259-61. Epub 2011 Nov 22. PMID:
22128012
Article Published Date
: Dec 01, 2011
Study Type
: In Vitro Study
Additional Links
Diseases
:
Anemia: Hemolytic : CK(76) : AC(8)
,
Blood Diseases : CK(30) : AC(2)
Anti Therapeutic Actions
:
Nanotechnology : CK(67) : AC(28)
Problem Substances
:
Polystyrene nanoparticles : CK(16) : AC(2)
Adverse Pharmacological Actions
:
Hemolytic : CK(17) : AC(4)
Print Options
Some features are currently member only features. If you are already a member, please
login
. Otherwise,
click here
to become a member.
Printer-friendly version
Send to friend
PDF version
Privacy Policy
Return Policy
About Us
Contact Us
Sitemap